Rekombinanter IL6 (Olokizumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter IL6 (Olokizumab Biosimilar) Antikörper (ABIN7829269)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Anti-IL6(olokizumab biosimilar) mAb
-
Isotyp
- IgG4
-
-
-
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- IL6 (Olokizumab Biosimilar)
-
Andere Bezeichnung
- Olokizumab Biosimilar
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
Synonyms Target:CDF,HGF,HSF,BSF2,IL-6,BSF-2,IFNB2,IFN-beta-2
Synonyms Antibody:Artlegia,CDP-6038,CDP6038,CDP 6038 -
UniProt
- P05231
Target
-